ASH 2023: Equity, Sickle Cell, and Real-Life OutcomesDecember 4, 2023Mixed TopicsBleeding DisordersAMLThrombosisTransplantMultiple MyelomaMyelodysplastic Syndrome
FDA approves JAK inhibitor momelotinib for myelofibrosis with anemiaSeptember 18, 2023CythemiasAnemiaAML
EHA and TIF explore how COVID-19 is affecting thalassemia and SCD patientsApril 20, 2020COVID-19 UpdatesAnemiaCythemias
